These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16515491)

  • 1. Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoring.
    Slish JC; Catanzaro LM; Ma Q; Okusanya OO; Demeter L; Albrecht M; Morse GD
    Curr Pharm Des; 2006; 12(9):1129-45. PubMed ID: 16515491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoring.
    Goicoechea M; Vidal A; Capparelli E; Rigby A; Kemper C; Diamond C; Witt MD; Haubrich R;
    Antivir Ther; 2007; 12(1):55-62. PubMed ID: 17503748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice.
    Maitre T; Muret P; Blot M; Waldner A; Duong M; Si-Mohammed A; Chavanet P; Aho S; Piroth L
    Curr HIV Res; 2019; 17(3):190-197. PubMed ID: 31490758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection.
    Pretorius E; Klinker H; Rosenkranz B
    Ther Drug Monit; 2011 Jun; 33(3):265-74. PubMed ID: 21566505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenetics, a valuable aid to therapeutic monitoring of immunosuppressives and antiretrovirals].
    Haufroid V
    Bull Mem Acad R Med Belg; 2011; 166(5-6):191-8; discussion 199-201. PubMed ID: 22891448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review.
    Cattaneo D; Baldelli S; Cozzi V; Clementi E; Marriott DJE; Gervasoni C;
    Ther Drug Monit; 2020 Feb; 42(1):64-74. PubMed ID: 31393332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it time to revise antiretrovirals dosing? a pharmacokinetic viewpoint.
    Cattaneo D; Baldelli S; Castoldi S; Charbe N; Cozzi V; Fucile S; Clementi E
    AIDS; 2014 Oct; 28(16):2477-80. PubMed ID: 25392858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.
    Punyawudho B; Singkham N; Thammajaruk N; Dalodom T; Kerr SJ; Burger DM; Ruxrungtham K
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1583-1595. PubMed ID: 27626677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
    Kiser JJ; Anderson PL; Gerber JG
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):61-7. PubMed ID: 16091250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.
    Neely MN; Rakhmanina NY
    Clin Pharmacokinet; 2011 Mar; 50(3):143-89. PubMed ID: 21294595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical issues in therapeutic drug monitoring of antiretroviral drugs.
    Van Heeswijk RP
    Ther Drug Monit; 2002 Jun; 24(3):323-31. PubMed ID: 12021621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues.
    Antonelli G
    Clin Microbiol Infect; 2010 Oct; 16(10):1509-10. PubMed ID: 20854461
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.
    Dickinson L; Khoo S; Back D
    Antiviral Res; 2010 Jan; 85(1):176-89. PubMed ID: 19665485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring in HIV infection: current status and future directions.
    Back D; Gatti G; Fletcher C; Garaffo R; Haubrich R; Hoetelmans R; Kurowski M; Luber A; Merry C; Perno CF
    AIDS; 2002 Mar; 16 Suppl 1():S5-37. PubMed ID: 12035820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of antiretroviral therapy.
    Di Perri G; Sinicco A; Audagnotto S; Gobbi F; Canta F; Marrone R; Bonora S
    New Microbiol; 2004 Apr; 27(2 Suppl 1):131-4. PubMed ID: 15646076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.
    Umeh OC; Currier JS
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):273-83. PubMed ID: 16866613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of antiretroviral therapy.
    Rakhmanina NY; van den Anker JN; Soldin SJ
    AIDS Patient Care STDS; 2004 Jan; 18(1):7-14. PubMed ID: 15006189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.